NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-195-2001-0-EP-08 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury EP DIV 06024432.4 Abandoned
NIBIB E-143-2000-0-GB-05 Sample Delivery System With Laminar Mixing for Microvolume BioSensing GB EP 01990651.0 Abandoned
NIBIB E-143-2000-0-FR-06 Sample Delivery System With Laminar Mixing for Microvolume BioSensing FR EP 01990651.0 Abandoned
NIBIB E-143-2000-0-DE-07 Sample Delivery System With Laminar Mixing for Microvolume BioSensing DE EP 01990651.0 Abandoned
NCI E-245-1994-0-US-08 CHIMERIC PAPILLOMA VIRUS-LIKE PARTICLES US CON 09/878,840 Abandoned
NCI E-216-2000-2-AU-06 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES AU National Stage 2001269762 Abandoned
NCI E-216-2000-2-BE-12 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES BE EP 01948294.2 Abandoned
NCI E-216-2000-2-AT-16 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES AT EP 01948294.2 Abandoned
NCI E-216-2000-2-DE-09 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES DE EP 01948294.2 Abandoned
NCI E-216-2000-2-FR-08 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES FR EP 01948294.2 Abandoned
NCI E-216-2000-2-IE-18 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES IE EP 01948294.2 Abandoned
NCI E-216-2000-2-IT-11 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES IT EP 01948294.2 Abandoned
NCI E-216-2000-2-DK-17 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES DK EP 01948294.2 Abandoned
NCI E-216-2000-2-SE-14 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES SE EP 01948294.2 Abandoned
NCI E-216-2000-2-GB-07 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES GB EP 01948294.2 Abandoned
NCI E-216-2000-2-CH-15 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES CH EP 01948294.2 Abandoned
NCI E-216-2000-2-NL-13 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES NL EP 01948294.2 Abandoned
NCI E-216-2000-2-ES-10 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES ES EP 01948294.2 Abandoned
NCI E-216-2000-2-EP-03 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES EP National Stage 01948294.2 Abandoned
NCI E-216-2000-2-PCT-01 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES PCT PCT COMB PCT/US2001/018503 Expired
NCI E-216-2000-2-JP-04 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES JP National Stage 2002-510119 Abandoned
NCI E-216-2000-2-CA-05 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES CA National Stage 2411967 Abandoned
NINDS E-232-1999-0-US-02 Controlling Attention and Memory By Altering Neuronal Carbonic Anhydrase Activity US ORD 09/875,283 6552053 Abandoned PDF
NICHD E-305-2001-0-PCT-02 VIP Related Peptides for the Treatment of Skin Disorders PCT PCT PCT/IL2001/000523 Expired
NINDS E-232-1999-0-PCT-03 Controlling Attention and Memory By Altering Neuronal Carbonic Anhydrase Activity. PCT PCT PCT/US01/018329 Abandoned
NHGRI E-167-2001-0-US-03 Hematopoietic Stem Cells Regeneration of Infarcted Myocardium US 60/295,805 Abandoned
NHGRI E-167-2001-0-US-04 Hematopoietic Stem Cells Regeneration of Infarcted Myocardium US 60/295,806 Abandoned
NHGRI E-167-2001-0-US-05 Hematopoietic Stem Cells Regeneration of Infarcted Myocardium US 60/295,807 Abandoned
NHGRI E-167-2001-0-US-02 Hematopoietic Stem Cells Regeneration of Infarcted Myocardium US 60/295,804 Abandoned
NCI E-114-2002-0-US-01 Apparatus and Method for Multiplex Blotting US 60/296,475 Abandoned
NHGRI E-167-2001-0-US-01 Hematopoietic Stem Cells Regeneration of Infarcted Myocardium US 60/295,803 Abandoned
NCI E-293-2000-0-US-01 Compositions And Methods Related to the Rig Tumor Suppressor Gene And Protein US ORD 09/873,546 Abandoned
NCI E-148-1998-1-US-01 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV GENES US CIP 09/872,733 6656706 Expired PDF
NCI E-175-2000-0-PCT-02 Superoxide-Generating Diazeniumdiolates, Compositions Comprising Same, And Methods For Using Same PCT PCT PCT/US01/17868 Expired
NIMH E-089-1998-1-US-01 Two Enterocin-Producing strains Of Bacteria And their Enterocins,Both Of Which Are Lethal To Vancomycin-Resistant Enterococcus Faecium...... US 60/294,593 Abandoned
NICHD E-147-1996-5-JP-04 Use of ADNF-For Enhancing Learning and Memory JP National Stage 2002-500944 Abandoned
NICHD E-147-1996-5-MX-06 Use of ADNF-For Enhancing Learning and Memory MX National Stage PA/A/2002/011923 Abandoned
NICHD E-147-1996-5-AU-07 Use of ADNF-For Enhancing Learning and Memory AU National Stage 2001275111 Abandoned
NICHD E-147-1996-5-BE-14 ADNF Mixtures For Enhancing Learning and Memory BE EP 01941783.1 Abandoned
NICHD E-147-1996-5-IE-18 ADNF Mixtures For Enhancing Learning and Memory IE EP 01941783.1 Abandoned
NICHD E-147-1996-5-FR-16 Use of ADNF-For Enhancing Learning and Memory FR EP 01941783.1 Abandoned
NICHD E-147-1996-5-DE-15 Use of ADNF-For Enhancing Learning and Memory DE EP 01941783.1 Abandoned
NICHD E-147-1996-5-LI-13 Use of ADNF-For Enhancing Learning and Memory LI EP 01941783.1 Abandoned
NICHD E-147-1996-5-GB-17 Use of Activity-Dependent Neurotrophic Factor-Derived Polypeptides for Enhancing Learning and Memory: Pre- and Post-Natal Administration GB EP 01941783.1 Abandoned
NICHD E-147-1996-5-CH-12 Use of ADNF-For Enhancing Learning and Memory CH EP 01941783.1 Abandoned
NICHD E-147-1996-5-EP-03 Use of ADNF-For Enhancing Learning and Memory: Pre- and Post- Natal Administration EP National Stage 01941783.1 Abandoned
NICHD E-147-1996-5-PCT-01 Use of ADNF-For Enhancing Learning and Memory PCT PCT COMB PCT/US01/17758 Abandoned
NICHD E-147-1996-5-EP-11 Use of ADNF-For Enhancing Learning and Memory EP DIV 1941783.1 Abandoned
NICHD E-147-1996-5-CA-08 Use of ADNF-For Enhancing Learning and Memory CA National Stage 2410735 Abandoned
NIMH E-110-1993-0-US-16 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM US CON 09/866,724 Abandoned